Samrat Pharmachem Ltd. - Research Center
530125 SAMRATPH Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
137.22 |
157.62 |
115.50 |
106.31 |
76.76 |
Operating profit |
1.00 |
21.14 |
18.77 |
5.58 |
4.28 |
Interest |
0.35 |
0.46 |
0.29 |
0.38 |
0.74 |
Gross profit |
1.31 |
20.86 |
18.80 |
5.42 |
3.58 |
EPS (Rs) |
1.37 |
49.45 |
43.50 |
12.12 |
7.24 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.66 |
0.18 |
0.33 |
0.23 |
0.04 |
Stock adjustment |
4.17 |
-12.35 |
-0.85 |
0.52 |
3.31 |
Raw material |
127.76 |
144.42 |
93.14 |
97.10 |
66.72 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
1.00 |
0.84 |
1.00 |
0.78 |
0.58 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
3.29 |
3.57 |
3.45 |
2.35 |
1.87 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.33 |
0.32 |
0.30 |
0.29 |
0.23 |
Taxation |
0.57 |
5.27 |
5.03 |
1.39 |
1.11 |
Net profit / loss |
0.42 |
15.28 |
13.44 |
3.74 |
2.24 |
Extra ordinary item |
- |
- |
-0.02 |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
3.09 |
3.09 |
3.09 |
3.09 |
3.09 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
0.73 |
13.41 |
16.25 |
5.25 |
5.57 |
GPM (%) |
.95 |
13.22 |
16.23 |
5.09 |
4.66 |
NPM (%) |
0.31 |
9.68 |
11.61 |
3.51 |
2.91 |